ARTICLE | Company News
Provalis, Pfizer deal
October 29, 2001 8:00 AM UTC
PRO acquired the U.K. marketing rights and inventory of Diclomax Retard and Diclomax SR anti-inflammatory drugs from Parke-Davis, a subsidiary of PFE, for £15.3 million ($22 million). The drugs are on...